2021 - Unravelling severe exacerbations of COPD ? CICERO an ERS CRC

The Collaboration In COPD ExaceRbatiOns (CICERO), an ERS clinical research collaboration (CRC), is an ambitious project with the overarching aim to understand and improve outcomes in severe COPD exacerbations across Europe. Education for healthcare professionals across Europe in severe exacerbations of COPD is a key aim of CICERO.

This research seminar provided the ideal platform for the launch of the educational aims of CICERO, wide engagement and discussion around key aspects of severe exacerbations, and brought together interested clinical academics from across Europe.

The aim of this research seminar was to redefine severe exacerbations of COPD, review upcoming biomarkers and identify key interventional needs. It also aims to highlight severe exacerbations as distinct events, with important differences to mild and moderate exacerbations.

2021 - Unravelling severe exacerbations of COPD ? CICERO an ERS CRC

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Welcome and introduction

K. Vermeersch (Leuven, Belgium)

Replay

Slides

Rehabilitation strategies around the time of hospitalisation

S. Singh (Leicester, United kingdom)

Replay

Slides

Accompanying documents

The CICERO CRC and CATALINA study

K. Vermeersch (Leuven, Belgium)

Replay

Accompanying documents

Session 5: New horizons for severe exacerbations of COPD - General discussion

Replay

What data should be collected during severe exacerbations?

F. Franssen (Maastricht, Netherlands)

Replay

Slides

Accompanying documents

What new biomarkers are on the horizon for severe exacerbations?

P. Burgel (Paris, France)

Replay

Slides

Round table discussion of breakout sessions (20min per group)

S. Ramakrishnan (Oxford, United Kingdom), I. Gyselinck (Leuven, Belgium)

Replay

Session 3: Treatments at preventing readmission to hospital for COPD - General discussion

Replay

Ventilation strategies during and after discharge from hospital

L. Pisani (Bologna, Italy)

Replay

Slides

Accompanying documents

How can treatable traits be used in severe exacerbations?

M. Bafadhel (Oxford, United Kingdom)

Replay

Slides

Accompanying documents

Pharmacological treatments

W. Janssens (Leuven, Belgium)

Replay

Accompanying documents

Session 2: Addressing the non-pulmonary features of hospitalisation for exacerbations of COPD - General discussion

Replay

Palliation and end-of-life care

D. Janssen (Horn, Netherlands)

Replay

Slides

Accompanying documents

Sarcopenia and muscle dysfunction

N. Greening (Leicester, United Kingdom)

Replay

Slides

Cardiac dysfunction

M. Contoli (Ferrara, Italy)

Replay

Slides

Session 1: Characterisation and features of severe exacerbations of COPD - General discussion

Replay

How can real-world data be used to improve outcomes?

J. Quint (London, United Kingdom)

Replay

Slides

Accompanying documents

Are severe and moderate exacerbations different entities?

T. Greulich (Marburg, Germany)

Replay

Slides

Remarks, wrap-up and action points

N. Greening (Leicester, United Kingdom), W. Janssens (Leuven, Belgium), M. Bafadhel (Oxford, United Kingdom)

Replay

2021 - Unravelling severe exacerbations of COPD ? CICERO an ERS CRC

2021 - Unravelling severe exacerbations of COPD ? CICERO an ERS CRC

#{title}